China Resources Boya Bio pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 23.15%

China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has an Asset Resilience Ratio of 23.15% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See China Resources Boya Bio pharmaceutical current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.95 Billion

≈ $284.73 Million USD Cash + Short-term Investments

Total Assets

CN¥8.41 Billion

≈ $1.23 Billion USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how China Resources Boya Bio pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see China Resources Boya Bio pharmaceutical (300294) total assets.

Liquid Assets Composition Over Time

This chart breaks down China Resources Boya Bio pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore China Resources Boya Bio pharmaceutical (300294) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.95 Billion	23.15%
Total Liquid Assets	CN¥1.95 Billion	23.15%

Asset Resilience Insights

Good Liquidity Position: China Resources Boya Bio pharmaceutical Group Co Ltd maintains a healthy 23.15% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

China Resources Boya Bio pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare China Resources Boya Bio pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for China Resources Boya Bio pharmaceutical Group Co Ltd (2015–2025)

The table below shows the annual Asset Resilience Ratio data for China Resources Boya Bio pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	30.79%	CN¥2.66 Billion ≈ $388.79 Million	CN¥8.63 Billion ≈ $1.26 Billion	+4.61pp
2024-12-31	26.18%	CN¥2.20 Billion ≈ $321.80 Million	CN¥8.40 Billion ≈ $1.23 Billion	-16.77pp
2023-12-31	42.95%	CN¥3.36 Billion ≈ $492.03 Million	CN¥7.83 Billion ≈ $1.15 Billion	+3.19pp
2022-12-31	39.76%	CN¥3.19 Billion ≈ $467.37 Million	CN¥8.03 Billion ≈ $1.18 Billion	+4.33pp
2021-12-31	35.42%	CN¥2.70 Billion ≈ $395.09 Million	CN¥7.62 Billion ≈ $1.12 Billion	+33.36pp
2016-12-31	2.07%	CN¥50.00 Million ≈ $7.32 Million	CN¥2.42 Billion ≈ $354.05 Million	+1.15pp
2015-12-31	0.91%	CN¥20.00 Million ≈ $2.93 Million	CN¥2.19 Billion ≈ $320.20 Million	--

pp = percentage points

About China Resources Boya Bio pharmaceutical Group Co Ltd

SHE:300294 China Biotechnology

Market Cap

$1.06 Billion

CN¥7.26 Billion CNY

Market Cap Rank

#8672 Global

#2080 in China

Share Price

CN¥14.40

Change (1 day)

+2.13%

52-Week Range

CN¥13.94 - CN¥25.48

All Time High

CN¥55.20